Cite
HARVARD Citation
Hilmi, M. et al. (2019). Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions. Journal for immunotherapy of cancer. 7 (1), p. . [Online].